- Home
- SATL vs SRDX Comparison
SATL vs SRDX Comparison
Compare SATL & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SATL
- SRDX
- Stock Information
- Founded
- SATL 2010
- SRDX 1979
- Country
- SATL United States
- SRDX United States
- Employees
- SATL N/A
- SRDX N/A
- Industry
- SATL Radio And Television Broadcasting And Communications Equipment
- SRDX Medical/Dental Instruments
- Sector
- SATL Technology
- SRDX Health Care
- Exchange
- SATL Nasdaq
- SRDX Nasdaq
- Market Cap
- SATL 357.1M
- SRDX 415.4M
- IPO Year
- SATL N/A
- SRDX 1998
- Fundamental
- Price
- SATL $3.50
- SRDX $32.38
- Analyst Decision
- SATL
- SRDX Buy
- Analyst Count
- SATL 0
- SRDX 3
- Target Price
- SATL N/A
- SRDX $43.00
- AVG Volume (30 Days)
- SATL 1.6M
- SRDX 318.4K
- Earning Date
- SATL 11-12-2025
- SRDX 11-05-2025
- Dividend Yield
- SATL N/A
- SRDX N/A
- EPS Growth
- SATL N/A
- SRDX N/A
- EPS
- SATL N/A
- SRDX N/A
- Revenue
- SATL $13,868,000.00
- SRDX $120,801,000.00
- Revenue This Year
- SATL N/A
- SRDX N/A
- Revenue Next Year
- SATL N/A
- SRDX $3.38
- P/E Ratio
- SATL N/A
- SRDX N/A
- Revenue Growth
- SATL 1.09
- SRDX N/A
- 52 Week Low
- SATL $0.93
- SRDX $26.00
- 52 Week High
- SATL $5.49
- SRDX $40.39
- Technical
- Relative Strength Index (RSI)
- SATL 48.12
- SRDX 35.24
- Support Level
- SATL $3.35
- SRDX $34.00
- Resistance Level
- SATL $3.79
- SRDX $34.74
- Average True Range (ATR)
- SATL 0.21
- SRDX 1.41
- MACD
- SATL -0.01
- SRDX -0.57
- Stochastic Oscillator
- SATL 46.30
- SRDX 2.66
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.